Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanara MedTech (SMTI) Common Equity (2016 - 2025)

Historic Common Equity for Sanara MedTech (SMTI) over the last 15 years, with Q3 2025 value amounting to $6.1 million.

  • Sanara MedTech's Common Equity fell 8454.41% to $6.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.1 million, marking a year-over-year decrease of 8454.41%. This contributed to the annual value of $39.4 million for FY2024, which is 1162.74% down from last year.
  • Sanara MedTech's Common Equity amounted to $6.1 million in Q3 2025, which was down 8454.41% from $35.4 million recorded in Q2 2025.
  • Sanara MedTech's Common Equity's 5-year high stood at $45.5 million during Q3 2022, with a 5-year trough of $6.1 million in Q3 2025.
  • In the last 5 years, Sanara MedTech's Common Equity had a median value of $39.4 million in 2024 and averaged $36.9 million.
  • Per our database at Business Quant, Sanara MedTech's Common Equity soared by 52544.11% in 2021 and then plummeted by 8454.41% in 2025.
  • Quarter analysis of 5 years shows Sanara MedTech's Common Equity stood at $30.6 million in 2021, then soared by 36.16% to $41.7 million in 2022, then grew by 6.87% to $44.6 million in 2023, then fell by 11.63% to $39.4 million in 2024, then crashed by 84.39% to $6.1 million in 2025.
  • Its last three reported values are $6.1 million in Q3 2025, $35.4 million for Q2 2025, and $36.7 million during Q1 2025.